Use of pimavanserin in patients with Parkinson's disease psychosis: subgroup analysis of efficacy and safety in patients with and without cognitive impairment

被引：0
|
作者：
Weintraub, D.
Norton, J.
Fredericks, D.
Coate, B.
Andersson, C.
Ballard, C.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Screening for cognitive impairment in patients with Parkinson's disease
    Sabatini, J.
    Berbetz, F.
    Jobbins, V.
    Tolentino, E.
    Bronzini, A.
    Ladeira, M.
    Lima, R.
    Young-Blood, M.
    Schultz, G.
    Camargo, C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E286 - E286
  • [32] Anticholinergic Use in Parkinson's Disease: Practice Patterns in Patients with Cognitive Impairment
    Shetty, N.
    Dubaz, O.
    Yu, Y.
    Gao, H.
    Simuni, T.
    MOVEMENT DISORDERS, 2020, 35 : S185 - S185
  • [33] Anticholinergic Use in Parkinson's Disease: Practice Patterns in Patients with Cognitive Impairment
    Shetty, Neil
    Dubaz, Ornella
    Yu, Yichao
    Gao, Hanzhi
    Simuni, Tanya
    NEUROLOGY, 2020, 94 (15)
  • [34] Pimavanserin in Alzheimer’s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms
    Clive Ballard
    J. M. Youakim
    B. Coate
    S. Stankovic
    The Journal of Prevention of Alzheimer's Disease, 2019, 6 : 27 - 33
  • [35] Long term pimavanserin treatment for Parkinson's disease psychosis (PDP) - An interim analysis of safety and tolerability
    Mills, R.
    Williams, H.
    Bahr, D.
    Chi-Burris, K.
    Ballard, C.
    MOVEMENT DISORDERS, 2013, 28 : S176 - S177
  • [36] Cognitive impairment in patients with Alzheimer's disease and Parkinson's disease
    Chyniak, O.
    MOVEMENT DISORDERS, 2021, 36 : S289 - S289
  • [37] Neuropsychological differences between Parkinson's disease patients with and without mild cognitive impairment
    Petrova, M.
    Raycheva, M.
    Zhelev, Y.
    Traykov, L.
    MOVEMENT DISORDERS, 2009, 24 : S307 - S307
  • [38] Motor differences between Parkinson's disease patients with and without mild cognitive impairment
    Petrova, M.
    Raycheva, M. R.
    Traykov, L. D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 64 - 64
  • [39] Metabolic biomarkers of appetite control in Parkinson's disease patients with and without cognitive impairment
    Siervo, Mario
    Johnston, Fionnuala
    Calton, Emily
    James, Anthony
    Stephan, Blossom C. M.
    Hornsby, Amanda K. E.
    Davies, Jeffrey S.
    Burn, David
    CLINICAL NUTRITION ESPEN, 2024, 64 : 425 - 434
  • [40] Safety assessment of pimavanserin in Parkinson's disease psychosis patients: Evidence from a systematic review and meta-analysis of randomized controlled trials
    Bano, G.
    Sharma, A.
    MOVEMENT DISORDERS, 2023, 38 : S230 - S230
12345